ClinicalTrials.gg
CompletedNCT05439187Updated Jun 30, 2022

Risk Factors of Venous Thromboembolism After Incisional Ventral Hernia Repair.

An observational study in Incisional Hernia and Venous Thromboembolism, sponsored by Pirogov Russian National Research Medical University. Completed at 1 site in Russia. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-06-30.

Sponsored by Pirogov Russian National Research Medical University · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
240
Ages
18 Years and older
Sex
All
01

Study summary

Aim of our study is to find frequency and risk factors for venous thromboembolism development in patients who underwent surgery for incisional ventral hernia. There were 240 patients enrolled in our retrospective observational cohort study. Included patients were operated for incisional hernia in Saveljev University Surgery Clinic from January 2018 to December 2019. Compression duplex ultrasound of lower legs veins was performed in 2-4 days after surgery for all participants. The primary endpoint was the occurrence of the venous thromboembolism event, including pulmonary embolism.

02

Conditions studied

  • Incisional Hernia
  • Venous Thromboembolism

Keywords

  • hernia repair
  • thromboprophylaxis
03

In context

Incisional Hernia

226 studies on the registry are indexed under Incisional Hernia; 53 are open to participants now.

This study's enrollment of 240 is above the median of 150 across 75 observational studies indexed under Incisional Hernia.

Browse Incisional Hernia studies →

Lead sponsor

Pirogov Russian National Research Medical University is the lead sponsor of 57 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

patients of Saveljev University Surgery Clinic, Moscow

Eligibility criteria

Inclusion Criteria:

  • operated for incisional hernia in Saveljev University Surgery Clinic No Exclusion Criteria.
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
240 participants (actual)
Patient registry
No

Interventions

  • Procedurehernia repair

    Open or laparoscopic hernia repair with mesh placement.

    Also known as: thromboprophylaxis

06

What researchers measure

Primary outcomes

  1. venous thromboembolism

    Screening ultrasound in the postoperative period was aimed at looking for signs of deep vein thrombosis. The imaged vessels included the common femoral, great saphenous, superficial femoral, deep femoral, popliteal, posterior tibial, and peroneal veins of both lower extremities. The presence of a thrombotic process in the vein was evidenced by the rigidity of its walls during compression by the sensor, the presence of hyperechoic inclusions, and the impossibility of visualizing blood flow during color mapping.

    Time frame: was performed with median 3 days (min 1 day, max 7 days, interquartile range 2-4 days) after surgery

07

Study locations

1 site
  • Pirogov Russian National Research Medical University
    Moscow, 117997, Russia
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 30, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05439187
Lead sponsor
Pirogov Russian National Research Medical University
Responsible party
Igor Zolotukhin (Professor, Pirogov Russian National Research Medical University) — Principal investigator
First posted
Jun 30, 2022
Start date
Jan 1, 2018
Primary completion
Dec 31, 2019
Completion
Jan 31, 2020
Last update
Jun 30, 2022

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion